Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Takeda Pharmaceutical Co's average basic shares outstanding for the quarter that ended in Mar. 2026 was 3,159 Mil.
Takeda Pharmaceutical Co (MEX:TAK N) Shares Outstanding (Basic Average) Explanation
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Be Aware
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Takeda Pharmaceutical Co Shares Outstanding (Basic Average) Related Terms
Takeda Pharmaceutical Co Shares Outstanding (Basic Average) Historical Data
* Premium members only.
The historical data trend for Takeda Pharmaceutical Co's Shares Outstanding (Basic Average) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co Shares Outstanding (Basic Average) Chart
Takeda Pharmaceutical Co Shares Outstanding (Basic Average) Calculation
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.
What does a Shares Outstanding (Basic Average) of 3,159 Mil mean?
Takeda Pharmaceutical Co (MEX:TAK N) has a Shares Outstanding (Basic Average) of 3,159 Mil as of Mar. 2026. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Takeda Pharmaceutical Co and its competitors.
Is Takeda Pharmaceutical Co's Shares Outstanding (Basic Average) too high?
Takeda Pharmaceutical Co's current Shares Outstanding (Basic Average) is 3,159 Mil. Overall, Takeda Pharmaceutical Co has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Shares Outstanding (Basic Average) compare to ZTS and UTHR?
Takeda Pharmaceutical Co's Shares Outstanding (Basic Average) of 3,159 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Drug Manufacturers company?
A good Shares Outstanding (Basic Average) depends on the Drug Manufacturers industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Takeda Pharmaceutical Co and its competitors. Takeda Pharmaceutical Co's current Shares Outstanding (Basic Average) is 3,159 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Takeda Pharmaceutical Co (MEX:TAK N) has a current Shares Outstanding (Basic Average) of 3,159 Mil. The stock's GF Value™ is MXN289.17, compared to a current price of MXN320.00 — trading 10.7% above its estimated fair value. The current Shares Outstanding (Basic Average) is 3,159 Mil. Takeda Pharmaceutical Co's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Takeda Pharmaceutical Co (MEX:TAK N), the current Shares Outstanding (Basic Average) is 3,159 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Takeda Pharmaceutical Co (MEX:TAK N) Overvalued in 2026?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued.
The current stock price of MXN320.00 is trading 10.7% above its estimated GF Value™ of MXN289.17.
Key valuation signals for MEX:TAK N:
Shares Outstanding (Basic Average): 3,159 Mil
GF Value™: MXN289.17 vs. price of MXN320.00 (10.7% above fair value)
No single metric tells the full story. See the MEX:TAK N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
67GF Score
Get the complete analysis for MEX:TAK N
Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TAK N has been successfully added to your 
